Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza

ClinicalTrials.gov ID: NCT01037205

Public ClinicalTrials.gov record NCT01037205. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01037205
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ansun Biopharma, Inc.
Industry
Enrollment
264 participants

Conditions and interventions

Conditions

Interventions

  • DAS181 dry powder, formulation F02 Drug
  • Respitose ML006 (DMV-Fonterra) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2009
Primary completion
Aug 31, 2011
Completion
Aug 31, 2011
Last update posted
Apr 7, 2014

2009 – 2011

United States locations

U.S. sites
42
U.S. states
21
U.S. cities
42
Facility City State ZIP Site status
Not listed Carmichael California
Not listed Chula Vista California
Not listed La Mesa California
Not listed Lincoln California
Not listed Los Angeles California
Not listed Orange California
Not listed Colorado Springs Colorado
Not listed Denver Colorado
Not listed Hialeah Florida
Not listed Miami Florida
Not listed Orlando Florida
Not listed Tampa Florida
Not listed Atlanta Georgia
Not listed Boise Idaho
Not listed Covington Louisiana
Not listed Silver Spring Maryland
Not listed North Dartmouth Massachusetts
Not listed Bellevue Nebraska
Not listed Henderson Nevada
Not listed Las Vegas Nevada
Not listed Stony Brook New York
Not listed Canton Ohio
Not listed Dayton Ohio
Not listed Franklin Ohio
Not listed Groveport Ohio
Not listed Miamisburg Ohio
Not listed Oklahoma City Oklahoma
Not listed Tulsa Oklahoma
Not listed Ashland Oregon
Not listed Lansdale Pennsylvania
Not listed Pittsburgh Pennsylvania
Not listed Myrtle Beach South Carolina
Not listed Simpsonville South Carolina
Not listed Rapid City South Dakota
Not listed Johnson City Tennessee
Not listed Austin Texas
Not listed Georgetown Texas
Not listed San Antonio Texas
Not listed Salt Lake City Utah
Not listed West Point Utah
Not listed West Valley City Utah
Not listed Richmond Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01037205, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 7, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01037205 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →